These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 7439373

  • 1. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV, Ovchinnikova LK, Zolotukhin SI.
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [Abstract] [Full Text] [Related]

  • 2. [Effect of complamine, nonachlazine, riboxine and clofeline on the fibrinogen content and fibrinolytic activity of the blood].
    Kremneva VF, Shevchenko LV.
    Farmakol Toksikol; 1980; 43(3):330-5. PubMed ID: 7449972
    [Abstract] [Full Text] [Related]

  • 3. [Influence of isoptin on the anticoagulant effect of the sodium and calcium salts of heparin].
    Ushkalova EA, Kremneva VF, Shcheglova NV.
    Farmakol Toksikol; 1988; 51(3):48-51. PubMed ID: 3410026
    [Abstract] [Full Text] [Related]

  • 4. [Influence of bigumal on the blood coagulation system and on the anticoagulant effect of heparin].
    kremneva VF, Ushkalova EA, Shcheglova NV.
    Farmakol Toksikol; 1986; 49(6):43-5. PubMed ID: 3817142
    [Abstract] [Full Text] [Related]

  • 5. [Effect of delagil on the blood coagulation system and the interrelation with heparin].
    Ovchinnikova LK, Pomortseva IV.
    Farmakol Toksikol; 1985; 48(2):77-81. PubMed ID: 3996575
    [Abstract] [Full Text] [Related]

  • 6. [The influence of the Soviet antimalarial preparation dabequin on the hemostatic system and on the anticoagulant effect of heparin].
    Pomortseva IV, Ovchinnikova LK, Shcheglova NV.
    Farmakol Toksikol; 1990; 53(1):59-62. PubMed ID: 2328805
    [Abstract] [Full Text] [Related]

  • 7. [The influence of ciprofloxacin and pefloxacin on blood coagulation and the anticoagulant effect of heparin].
    Lepakhin VK, Ushkalova EA, Shcheglova NV.
    Farmakol Toksikol; 1989; 52(5):33-6. PubMed ID: 2599074
    [Abstract] [Full Text] [Related]

  • 8. [Interaction of the calcium salt of heparin with specific antagonists and ethacizine].
    Ushkalova EA, Petrov AD, Kremneva VF, Shcheglova NV.
    Farmakol Toksikol; 1988; 51(6):53-6. PubMed ID: 3234542
    [Abstract] [Full Text] [Related]

  • 9. [Effect of etatsizin on blood coagulability and the anticoagulant effect of heparin].
    Petrov AD.
    Farmakol Toksikol; 1985; 48(4):112-4. PubMed ID: 4043358
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Study of the interrelations of ethmozine, cordarone and phenycaberan with heparin].
    Tolstopiatov BI.
    Farmakol Toksikol; 1981; 44(5):586-9. PubMed ID: 7030776
    [Abstract] [Full Text] [Related]

  • 12. Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo.
    Li DW, Lee IS, Sim JS, Toida T, Linhardt RJ, Kim YS.
    Thromb Res; 2004; 113(1):67-73. PubMed ID: 15081567
    [Abstract] [Full Text] [Related]

  • 13. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ, Mahadoo J, Jaques LB.
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [Abstract] [Full Text] [Related]

  • 14. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS, Rozkin MIa, Poberiĭ IA, Lindner DP.
    Farmakol Toksikol; 1981 Mar; 44(1):80-5. PubMed ID: 7262304
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The mechanism of action of riboxin].
    Dunaev VV, Tishkin VS, Evdokimov EI, Belaĭ IM.
    Farmakol Toksikol; 1989 Mar; 52(6):56-8. PubMed ID: 2483141
    [Abstract] [Full Text] [Related]

  • 17. [Mechanisms of action of nonachlazine].
    Oganesian NM, Oganesian SS, Varosian MA, Bagramian IG, Barinian SB.
    Farmakol Toksikol; 1981 Mar; 44(3):283-7. PubMed ID: 7286184
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of blood coagulation and fibrinolysis by polyamines in the presence of glycosaminoglycans.
    Homma R, Mase A, Toida T, Kashiwagi K, Igarashi K.
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1911-20. PubMed ID: 15936241
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model.
    Callé R, Rochefort GY, Desbuards N, Plag C, Antier D, Ossant F.
    Ultrasound Med Biol; 2010 Feb; 36(2):295-305. PubMed ID: 20045589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.